Document Detail


Consideration of dual characters of exosomes in the tumour immune response.
MedLine Citation:
PMID:  24523154     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Efforts to get a strong and sustained anti-tumour immune response induced by a tumour specific antigen have failed, but sipuleucel-T has been approved by the US Food and Drug Administration (FDA). We noticed that exosomes secreted by tumour cells or immune cells may be crucially involved in the tumour immune response, whereas others have had inconsistent findings on exosome involvement. Based on immune network theory, we summarise research advances of exosomes and speculate that in the tumour immune response exosomes follow the immune response curve hypothesis. Exosomes activate simultabeously both immune activation and immune tolerance, but at different intensities. To obtain a desired anti-immune response, the initial point of immunity should be determined to achieve the strongest anti-tumour response, and repeated in vitro to extend and enhance this response. As a result, our hypothesis proposes that studies should now be directed at determining the exact time of exosome activity in maintaining a viable anti-tumour immune response in vivo.
Authors:
Jun Bai; Xin Xie; Yun Lei; Gaili An; Li He; Ruping Chen
Related Documents :
24523154 - Consideration of dual characters of exosomes in the tumour immune response.
12464154 - Cytokine blocking agents in dermatology.
17320974 - Alteration of the cortisol-cortisone shuttle in leprosy type 1 reactions in leprosy pat...
20865844 - Mechanism of action and clinical benefits of colloidal oatmeal for dermatologic practice.
12220554 - Regulation of cytokine signaling and inflammation.
7544394 - Erythrocyte stages of plasmodium falciparum exhibit a high nitric oxide synthase (nos) ...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-11-12
Journal Detail:
Title:  Cell biology international     Volume:  -     ISSN:  1095-8355     ISO Abbreviation:  Cell Biol. Int.     Publication Date:  2013 Nov 
Date Detail:
Created Date:  2014-2-13     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9307129     Medline TA:  Cell Biol Int     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
© 2014 International Federation for Cell Biology.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Highlights From the 2013 ACCF/AHA Guidelines for the Management of ST-Elevation Myocardial Infarctio...
Next Document:  Adjusting for centre heterogeneity in multicentre clinical trials with a time-to-event outcome.